JILL PEASE: Open Payments
NPI 1619951126 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 77 payments from 9 companies in 2025. Trend: 2023 $1,315 · 2024 $1,056 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $530 |
| PFIZER INC. | 9 | $171 |
| Indivior Inc. | 12 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $138 |
| Corium, LLC | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Braeburn Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, NURTEC ODT, SUBLOCADE, CAPLYTA, QULIPTA, CREON, Azstarys.
Industry payments across IN — which companies pay providers there.
